Cargando…
Validation of an LC-MS/MS Method to Quantify the New TRPC6 Inhibitor SH045 (Larixyl N-methylcarbamate) and Its Application in an Exploratory Pharmacokinetic Study in Mice
TRPC6 (transient receptor potential cation channels; canonical subfamily C, member 6) is widespread localized in mammalian tissues like kidney and lung and associated with progressive proteinuria and pathophysiological pulmonary alterations, e.g., reperfusion edema or lung fibrosis. However, the und...
Autores principales: | Chai, Xiao-Ning, Ludwig, Friedrich-Alexander, Müglitz, Anne, Schaefer, Michael, Yin, Hai-Yan, Brust, Peter, Regenthal, Ralf, Krügel, Ute |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000919/ https://www.ncbi.nlm.nih.gov/pubmed/33805686 http://dx.doi.org/10.3390/ph14030259 |
Ejemplares similares
-
A Pharmacokinetic and Metabolism Study of the TRPC6 Inhibitor SH045 in Mice by LC-MS/MS
por: Chai, Xiao-Ning, et al.
Publicado: (2022) -
In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome
por: Zheng, Zhihuang, et al.
Publicado: (2022) -
Simultaneous determination of methylcarbamate and ethylcarbamate in fermented foods and beverages by derivatization and GC-MS analysis
por: Shin, Ho-Sang, et al.
Publicado: (2012) -
The TRPC6 inhibitor, larixyl acetate, is effective in protecting against traumatic brain injury-induced systemic endothelial dysfunction
por: Chen, Xingjuan, et al.
Publicado: (2019) -
Progress and Challenges in Quantifying Carbonyl-Metabolomic Phenomes with LC-MS/MS
por: Sun, Yuting, et al.
Publicado: (2021)